Testimony & Official Correspondence

Wednesday, November 26, 2008
Download the letter PDF version. Stephen W. Golsby President, Mead Johnson & Company 2400 W. Lloyd Expressway Evansville, IN 47721 Re: Melamine in baby formula

Tuesday, November 18, 2008

Regarding proposed amendment of 21 CFR Parts 129 and 165
Docket No. FDA-2008-N-0446

Download as PDF file.

Monday, November 3, 2008

October 31, 2008

Testimony by Olga V. Naidenko, Ph.D.

Hello, I'm Olga Naidenko, Senior Scientist at Environmental Working Group. I am grateful for this opportunity to present EWG position regarding the FDA's draft risk assessment for BPA in food packaging.

Monday, October 20, 2008


Office of Pesticide Programs (OPP)
Regulatory Public Docket (7502P)
Environmental Protection Agency
1200 Pennsylvania Ave., NW.
Washington, DC 20460-0001

October 20, 2008

Regarding: Docket EPA-HQ-OPP-2006-0573; FRL-8376-9
Proposed Quaternary Ammonium Compound Food Tolerance Exemption

To Whom It May Concern:

Wednesday, September 24, 2008


Before the United States Senate Committee on Commerce, Science & Transportation

Wednesday, September 24, 2008, at 2:30 pm - Submitted for the Record

Download PDF file of this testimony.

Key Issues: 
Thursday, September 18, 2008


Maine Center for Disease Control and Prevention to The House Committee on Energy and Commerce Science Under Siege: Scientific Integrity and the Environmental Protection Agency

Download PDF file of this testimony.

Monday, September 15, 2008

Oversight Hearing on Natural Gas Drilling in the New York City Watershed Before the New York City Council Committee on Environmental Protection

Wednesday, September 10, 2008 at 1:00 p.m.

Submitted for the Record


Thursday, October 30, 2008

Download these comments as a PDF.

September 12, 2008

Martin Philbert, PhD

BPA Subcommittee Chair

c/o Office of Science and Health Coordination

Office of the Commissioner (HF-33)

Food and Drug Administration

Rockville, MD 20857

Re: Comments on the FDA's draft assessment of Bisphenol A (BPA)

Dear Dr. Philbert:

Monday, August 18, 2008


FDA’s Flawed Assessment of Bisphenol A Safety Underscores the Need for State and Federal Legislation

An Environmental Working Group (EWG) analysis of FDA’s draft assessment of BPA revealed a number of critical flaws and built in assumptions that biased the agency’s evaluation and ensured that the FDA would find current exposure levels in the population to be safe.

Laboratory studies show BPA harms brain development, raising concerns about its presence in baby bottles and other products that could expose babies and young children.

Key Issues: